In AD, AD brains retain significantly more cholesterol than age-matched nondementia control (ND) brains; the APP acts as a lipid-sensing peptide on cholesterol and forms MAMs in the ER, causing extracellular cholesterol internalization in the ER (Montesinos et al., 2020). Here, APP is linked to Alzheimer disease.